Profectus BioPharmaceuticals Files Form 10Q Quarterly Report with SEC Controladora VLRS Stock Analysis 191 Loss Key Levels 20260518 Wall Street Futures Edge Higher as Markets Await Key Inflation Data Fed Dissenters Explain No Votes Objecting to Signal That Next Move Would Be a Cut BioAtla BCAB Q4 2025 Earnings Why the Beat Matters NOVONIX NVX Drops 215 Key Support at 061 20260514 Am Vanguard AVD Q3 2025 Earnings Miss Sparks Concern